Kaletra and Ear neoplasm malignant - from FDA reports


Summary

Ear neoplasm malignant is reported only by a few people who take Kaletra. We study 17,222 people who have side effects while taking Kaletra from FDA. Among them, 1 have Ear neoplasm malignant. Find out below who they are, when they have Ear neoplasm malignant and more.

What to expect?

If you take Kaletra and have Ear neoplasm malignant, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Kaletra and have Ear neoplasm malignant

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Nov, 19, 2017

17,222 people reported to have side effects when taking Kaletra.
Among them, 1 person (0.01%) has Ear neoplasm malignant


Number of reports submitted per year:

Could Kaletra cause Ear neoplasm malignant?

Gender of people who have Ear neoplasm malignant when taking Kaletra *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Ear neoplasm malignant when taking Kaletra *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Top conditions involved for these people *:

  • Neoplasm Malignant (1 person, 100.00%)

Top co-used drugs for these people *:

  • Combivir (1 person, 100.00%)

Top other side effects for these people *:

  • Neoplasm Malignant (1 person, 100.00%)
  • Nasal Cavity Cancer (1 person, 100.00%)
  • Epidermolysis (1 person, 100.00%)
  • Cancer - Throat Or Larynx (1 person, 100.00%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Ear neoplasm malignant when taking Kaletra?

Expand the study to include all drugs with the same ingredients

Ear neoplasm malignant and drugs with ingredients of lopinavir; ritonavir.

Expand the study to include reports from both FDA and eHealthMe

Ear neoplasm malignant and Kaletra from FDA and eHealthMe reports

Kaletra

Kaletra has active ingredients of lopinavir; ritonavir. It is often used in hiv infection. (latest outcomes from Kaletra 17,412 users)

Ear neoplasm malignant

Ear neoplasm malignant (ear cancerous tumour) has been reported by people with rheumatoid arthritis, multiple sclerosis, atrial fibrillation/flutter, myelodysplastic syndrome, type 2 diabetes (latest reports from 76 Ear neoplasm malignant patients).

Browse all side effects of Kaletra

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Ear neoplasm malignant

Ear neoplasm malignant

Could your condition cause Ear neoplasm malignant

Ear neoplasm malignant

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Kaletra and have Ear neoplasm malignant.

Questions to the study

More questions >

User reviews to the study

More reviews >